Fischer Medical Ventures Ltd
Mon 3/11/2025,15:59:36 | NSE : FISCHER
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 119.29
Previous Close
₹ 117.71
Volume
2391334
Mkt Cap ( Rs. Cr)
₹6943.66
High
₹ 119.40
Low
₹ 106.18
52 Week High
₹ 124.70
52 Week Low
₹ 77.01
Book Value Per Share
₹ 4.75
Dividend Yield
0.04
Face Value
₹ 1.00
What’s Your Call?
Collective community sentiment on Fischer Medical Ventures Ltd
Your Vote -
Buy
66.67%
Hold
0.00%
Sell
33.33%
66.67%
3 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
100%
Sell Order Quantity
0%
Bid Price
Qty
107.07
98
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
98
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Fischer Medical Ventures Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Fischer Medical Vent - Copy of Newspaper Publication
-
Fischer Medical Vent - Update On Latest Corporate Presentation
-
Fischer Medical Vent - General Updates
-
Fischer Medical Vent - Shareholders meeting
-
Fischer Medical Vent - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
-
Fischer Medical Vent - Press Release
-
Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Fischer Medical Vent - Outcome of Board Meeting
-
Fischer Medical Vent - General Updates
-
Fischer Medical Vent - Update On Material Subsidiary
-
Fischer Medical Vent - Shareholders meeting
-
Fischer Medical Vent - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
-
Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Change in Management
-
Fischer Medical Vent - Appointment
-
Fischer Medical Vent - Results - Financial Results 30.09.2025
-
Fischer Medical Vent - Outcome of Board Meeting
-
Fischer Medical Vent - Board Meeting Outcome for Board Meeting Outcome
-
Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
-
Fischer Medical Vent - Monitoring Agency Report
-
Fischer Medical Vent - Press Release
-
Fischer Medical Vent - Board Meeting Intimation for Consideration And Approval Of Unaudited Quarterly Results For The Period
-
Nanomedic secures NHS Nod, Eyes India Launch and US FDA Filing
-
Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Fischer Medical Vent - Press Release
-
Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Fischer Medical Vent - General Updates
-
Fischer Medical Vent - Announcement Relating To Wholly Owned Subsidiary
-
Fischer Medical Vent - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Fischer Medical Vent - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Fischer Medical Vent has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025
-
Fischer Medical Vent - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Fischer Medical Vent - Shareholders meeting
-
Fischer Medical Vent - Trading Window
-
Fischer Medical Vent - Shareholders meeting
-
Fischer Medical Vent - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Fischer Medical Vent - Shareholder Meeting / Postal Ballot-Outcome of AGM
-
Fischer Medical Vent - Reg. 34 (1) Annual Report.
-
Fischer Medical Vent has submitted to BSE the Shareholding Pattern for the Period Ended September 12, 2025
-
Fischer Medical Vent - General Updates
-
Fischer Medical Vent - Dividend Clarification
-
Fischer Medical Vent - Copy of Newspaper Publication
-
Fischer Medical Vent - Record Date
-
Fischer Medical Vent - Shareholders meeting
-
Fischer Medical Vent - The Company Has Fixed The 12Th September 2025 As The Record Date For The Purpose Of Determining The El
-
Fischer Medical Vent - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report
-
Fischer Medical Vent has declared 0.50% Final dividend for the financial year March 2025
-
Fischer Medical Vent - General Updates
-
Fischer Medical Vent - General Update
-
Fischer Medical Vent - Outcome Of Board Meeting Held On 14.08.2025
-
Fischer Medical Vent - General Updates
-
Fischer Medical Vent - Resignation of Independent director
-
Fischer Medical Vent - Record Date
-
Fischer Medical Vent - Disclosure of material issue
-
Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Resignation of Director
-
Fischer Medical Vent - Outcome of Board Meeting
-
Fischer Medical Vent - Outcome of Board Meeting
-
Fischer Medical Vent - Outcome of Board Meeting
-
Fischer Medical Vent - Corporate Action For Dividend & E- Voting - 22/09/2025
-
Fischer Medical Vent - Results - June 2025
-
Fischer Medical Vent - Results-30.06.2025
-
Fischer Medical Vent - Results -30.06.2025
-
Fischer Medical Vent - Board Meeting Outcome for Outcome Of Board Meeting Held On 14.08.2025
-
Fischer Medical Vent - Monitoring Agency Report
-
Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
-
Fischer Medical Vent - Board Meeting Intimation for Financial Results For The Quarter Ended 30Th June 2025 And Other Matters
Key fundamentals
Evaluate the intrinsic value of Fischer Medical Ventures Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 335.685 | 79.6794 | 0.3057 | 0.1597 | 0.2359 |
| Liabilities | 335.685 | 79.6794 | 0.3057 | 0.1597 | 0.2359 |
| Equity | 63.8015 | 53.5 | 0.172 | 0.172 | 0.172 |
| Gross Profit | -2.2373 | -0.1952 | 0.0152 | -0.1887 | -0.1825 |
| Net Profit | 0.6632 | 0.4028 | -0.0365 | -0.2326 | 0.1406 |
| Cash From Operating Activities | -24.1034 | 0.0796 | -0.1459 | -0.1769 | -0.0573 |
| NPM(%) | 12.7 | 3.49 | -20.33 | 0 | 0 |
| Revenue | 5.2196 | 11.5283 | 0.1795 | 0 | 0 |
| Expenses | 7.4569 | 11.7235 | 0.1643 | 0.1887 | 0.1825 |
| ROE(%) | 0.21 | 0.13 | -0.01 | -0.07 | 0.04 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Fischer Medical Ventures Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Sharda Cropchem Ltd | 816.80 | -5.54 | 16.31 | 1061.44 | 337.37 | 1.10 |
| Amines and Plasticizers Ltd | 214.59 | -1.02 | 29.68 | 647.31 | 372.61 | 0.23 |
| Indogulf Cropsciences Ltd | 104.05 | 0.40 | 0.00 | 276.70 | 49.78 | 0.00 |
| Grauer and Weil (India) Ltd | 115.60 | 0.00 | 34.92 | 5334.39 | 346.70 | 0.43 |
Company Info
The Company was incorporated as a Public Limited Company on 22nd March 1993, and obtained certificate of commencement of business on 19th August 1993. The Company entered into an agreement with the Partnership firm M/s. Fischer Inorganics & Aromatics, Madras to take over the partnership business as a going concern without any break as per the agreement dated 19th January 1994. To fully exploit the vast potential and growth prospects available for the various grades of laboratory chemicals particularly after the delicensing of the industry,the promoters have thought fit to put up a larger capacity project so as to achieve the economies of scale of production and marketing. The partnership firm has been engaged in the Processing/Manufacturing of Laboratory Grade Chemicals, for about 10 years. PRESENT BUSINESS The Company is already engaged in the manufacture of certain grades of Laboratory Chemicals in its plant situated at Aminjikarai and Palavakkam, near Madras city (taken over from the partnership firm M/s Fischer Inorganics and Aromatics). These Grades of Laboratory Chemicals are broadly clasified as SALTS, SOLVENTS & ACIDS which include 1. Laboratory & Analytical Reagent Grade Chemicals (LR & AR Grade) used in QC/R & D Lab. of Industries / Institutions 2. Electronic Reagent Grade Chemicals (EL Grade) used in the Process of both Manufacturing & Assembling Electronic Industries. 3. IP Grade Chemicals used in Pharmaceutical Industries. 4. Diagnostic Grade Chemicals used in Hospitals/Clinical Laboratories for either Bio-Chemical or Histopathological Estimations. 2003 -Fischer Chem gets ISO 9001:2000 certification by M/s. RWTUV of Germany 2008 -Fischer Chemic has designated E-mail ID for Investors Complaints: fischerlab@vsnl.net 2013 -Company has changed its Registered Office from No. 3/240, Govindan Nagar, Palavakkam, Chennai - 600041, Tamilnadu to First Floor, Silver Sky Super Market Complex, New No. 15 Gangai Amman Koil Street, Kodambakkam, Chennai - 600 024, Tamilnadu.
The Company was incorporated as a Public Limited Company on 22nd March 1993, and obtained certificate of commencement of business on 19th August 1993. The Company entered into an agreement with the Partnership firm M/s. Fischer Inorganics & Aromatics, Madras to take over the partnership business as a going concern without any break as per the agreement dated 19th January 1994. To fully exploit the vast potential and growth prospects available for the various grades of laboratory chemicals particularly after the delicensing of the industry,the promoters have thought fit to put up a larger capacity project so as to achieve the economies of scale of production and marketing. The partnership firm has been engaged in the Processing/Manufacturing of Laboratory Grade Chemicals, for about 10 years. PRESENT BUSINESS The Company is already engaged in the manufacture of certain grades of Laboratory Chemicals in its plant situated at Aminjikarai and Palavakkam, near Madras city (taken over from the partnership firm M/s Fischer Inorganics and Aromatics). These Grades of Laboratory Chemicals are broadly clasified as SALTS, SOLVENTS & ACIDS which include 1. Laboratory & Analytical Reagent Grade Chemicals (LR & AR Grade) used in QC/R & D Lab. of Industries / Institutions 2. Electronic Reagent Grade Chemicals (EL Grade) used in the Process of both Manufacturing & Assembling Electronic Industries. 3. IP Grade Chemicals used in Pharmaceutical Industries. 4. Diagnostic Grade Chemicals used in Hospitals/Clinical Laboratories for either Bio-Chemical or Histopathological Estimations. 2003 -Fischer Chem gets ISO 9001:2000 certification by M/s. RWTUV of Germany 2008 -Fischer Chemic has designated E-mail ID for Investors Complaints: fischerlab@vsnl.net 2013 -Company has changed its Registered Office from No. 3/240, Govindan Nagar, Palavakkam, Chennai - 600041, Tamilnadu to First Floor, Silver Sky Super Market Complex, New No. 15 Gangai Amman Koil Street, Kodambakkam, Chennai - 600 024, Tamilnadu.
Read More
Parent Organisation
Fischer Medical Ventures Ltd.
Founded
22/03/1993
Managing Director
Mr.Ravindran Govindan
NSE Symbol
FISCHEREQ
FAQ
The current price of Fischer Medical Ventures Ltd is ₹ 107.07.
The 52-week high for Fischer Medical Ventures Ltd is ₹ 119.40 and the 52-week low is ₹ 106.18.
The market capitalization of Fischer Medical Ventures Ltd is currently ₹ 6943.66. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Fischer Medical Ventures Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Fischer Medical Ventures Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Fischer Medical Ventures Ltd shares.
The CEO of Fischer Medical Ventures Ltd is Mr.Ravindran Govindan, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.